sb 203580 has been researched along with Acute Confusional Senile Dementia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bignante, EA; Lorenzo, A | 1 |
Bertz, J; Gladbach, A; Ittner, AA; Ittner, LM; Suh, LS | 1 |
Bu, N; Du, Y; Liu, JJ; Wu, HQ; Yao, L; Yuan, HF; Zhang, GL; Zhang, R | 1 |
Desobry, K; Gay, D; Grammas, P; Luo, J; Martinez, J; Riley, J; Sanchez, A; Tripathy, D; Yin, X | 1 |
Aiso, S; Chiba, T; Hashimoto, Y; Ichijo, H; Ishizaka, M; Kadowaki, H; Nawa, M; Niikura, T; Nishimoto, I; Nishitoh, H; Terashita, K; Tsukamoto, E; Yamada, M; Yamagishi, Y | 1 |
González-Billault, C; Maccioni, RB; Orellana, DI; Quintanilla, RA | 1 |
6 other study(ies) available for sb 203580 and Acute Confusional Senile Dementia
Article | Year |
---|---|
APP signaling in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Anti-Inflammatory Agents, Non-Steroidal; Gene Expression Regulation; Humans; Imidazoles; Protein Aggregation, Pathological; Pyridines; Signal Transduction | 2018 |
p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Dizocilpine Maleate; Electrodes, Implanted; Electroencephalography; Enzyme Inhibitors; Epilepsy; Excitatory Amino Acid Antagonists; Gamma Rhythm; Hippocampus; Imidazoles; Male; Mice, Inbred C57BL; Mice, Transgenic; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, N-Methyl-D-Aspartate; Riluzole; Theta Rhythm | 2014 |
[Expression of p38MAPK in the olfactory bulb of rats with Alzheimer's disease].
Topics: Alzheimer Disease; Animals; Enzyme Inhibitors; Imidazoles; Male; Olfactory Bulb; p38 Mitogen-Activated Protein Kinases; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction | 2009 |
p38 MAPK: a mediator of hypoxia-induced cerebrovascular inflammation.
Topics: Alzheimer Disease; Animals; Cell Hypoxia; Cells, Cultured; Cerebrovascular Disorders; Encephalitis; Humans; Imidazoles; Mice; Mice, Transgenic; Microvessels; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats | 2012 |
The cytoplasmic domain of Alzheimer's amyloid-beta protein precursor causes sustained apoptosis signal-regulating kinase 1/c-Jun NH2-terminal kinase-mediated neurotoxic signal via dimerization.
Topics: Adaptor Proteins, Signal Transducing; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anthracenes; Carrier Proteins; Dimerization; Epidermal Growth Factor; ErbB Receptors; Flavonoids; Humans; Hybrid Cells; Imidazoles; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mice; Mitogen-Activated Protein Kinases; Neurons; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Protein Structure, Tertiary; Proteins; Pyridines; Rats; Signal Transduction | 2003 |
Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway.
Topics: Alzheimer Disease; Animals; Cell Culture Techniques; Cell Survival; DNA Primers; Enzyme Inhibitors; Flavonoids; Hippocampus; Humans; Imidazoles; Interleukin-6; Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Neurons; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; tau Proteins | 2004 |